Growth Metrics

AC Immune (ACIU) Asset Utilization Ratio (2016 - 2025)

AC Immune (ACIU) reported Asset Utilization Ratio of 0.02 for Q4 2025, down 83.88% year-over-year from 0.13 in Q4 2024, and down 9.5% on a QoQ basis from 0.02 in Q3 2025.

AC Immune (ACIU) has 7 years of Asset Utilization Ratio data on file, last reported at 0.02 in Q4 2025.

  • Quarterly Asset Utilization Ratio fell 83.88% year-over-year to 0.02 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02 (down 83.88% YoY) and the FY2025 annual result came in at 0.02, down 85.56% from the prior year.
  • Asset Utilization Ratio retreated to 0.02 in Q4 2025 per ACIU's latest filing, from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.14 in Q2 2025 and bottomed at 0.02 in Q4 2025.
  • The 3-year median for Asset Utilization Ratio is 0.08 (2022), against an average of 0.08.
  • Peak annual rise in Asset Utilization Ratio reached 362.41% in 2025, while the deepest fall reached 83.88% in 2025.
  • Tracing ACIU's Asset Utilization Ratio over 3 years: stood at 0.03 in 2022, then surged by 283.87% to 0.13 in 2024, then tumbled by 83.88% to 0.02 in 2025.
  • Per Business Quant, the three latest ACIU Asset Utilization Ratio figures stand at 0.02 (Q4 2025), 0.02 (Q3 2025), and 0.14 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 AC Immune 325.88 Mn 211.53 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.02
Sep 30, 2025 0.02
Jun 30, 2025 0.14
Mar 31, 2025 0.13
Dec 31, 2024 0.13
Sep 30, 2024 0.13
Jun 30, 2024 0.03
Sep 30, 2022 0.03
Dec 31, 2020 0.06
Sep 30, 2020 0.06
Jun 30, 2020 0.06
Mar 31, 2020 0.06
Dec 31, 2019 0.26
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.32
Mar 31, 2017 0.13
Dec 31, 2016 0.11